JP2010538680A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538680A5
JP2010538680A5 JP2010526034A JP2010526034A JP2010538680A5 JP 2010538680 A5 JP2010538680 A5 JP 2010538680A5 JP 2010526034 A JP2010526034 A JP 2010526034A JP 2010526034 A JP2010526034 A JP 2010526034A JP 2010538680 A5 JP2010538680 A5 JP 2010538680A5
Authority
JP
Japan
Prior art keywords
individual
activation
pi3k pathway
epithelial cells
airway epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010526034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538680A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/077136 external-priority patent/WO2009039457A1/en
Publication of JP2010538680A publication Critical patent/JP2010538680A/ja
Publication of JP2010538680A5 publication Critical patent/JP2010538680A5/ja
Pending legal-status Critical Current

Links

JP2010526034A 2007-09-19 2008-09-19 肺疾患に対する薬剤開発のための新規経路の同定 Pending JP2010538680A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99464307P 2007-09-19 2007-09-19
PCT/US2008/077136 WO2009039457A1 (en) 2007-09-19 2008-09-19 Identification of novel pathways for drug development for lung disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014155833A Division JP2014204737A (ja) 2007-09-19 2014-07-31 肺疾患に対する薬剤開発のための新規経路の同定

Publications (2)

Publication Number Publication Date
JP2010538680A JP2010538680A (ja) 2010-12-16
JP2010538680A5 true JP2010538680A5 (https=) 2012-10-11

Family

ID=40468411

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010526034A Pending JP2010538680A (ja) 2007-09-19 2008-09-19 肺疾患に対する薬剤開発のための新規経路の同定
JP2014155833A Pending JP2014204737A (ja) 2007-09-19 2014-07-31 肺疾患に対する薬剤開発のための新規経路の同定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014155833A Pending JP2014204737A (ja) 2007-09-19 2014-07-31 肺疾患に対する薬剤開発のための新規経路の同定

Country Status (7)

Country Link
US (3) US20090186951A1 (https=)
EP (1) EP2193211A4 (https=)
JP (2) JP2010538680A (https=)
CN (1) CN101990577A (https=)
AU (1) AU2008302076B2 (https=)
CA (1) CA2700200A1 (https=)
WO (1) WO2009039457A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2552686A1 (en) * 2003-11-12 2005-05-26 Trustees Of Boston University Isolation of nucleic acid from mouth epithelial cells
US20100035244A1 (en) 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
PE20090368A1 (es) 2007-06-19 2009-04-28 Boehringer Ingelheim Int Anticuerpos anti-igf
JP2010538680A (ja) 2007-09-19 2010-12-16 ザ トラスティーズ オブ ボストン ユニバーシティー 肺疾患に対する薬剤開発のための新規経路の同定
US20100055689A1 (en) * 2008-03-28 2010-03-04 Avrum Spira Multifactorial methods for detecting lung disorders
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
NZ592151A (en) 2008-12-12 2012-10-26 Boehringer Ingelheim Int Anti-igf antibodies
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
US9895321B2 (en) * 2010-04-23 2018-02-20 Aktiv-Dry Llc Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
WO2012130720A2 (en) * 2011-03-28 2012-10-04 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh PREDICTION OF RESPONSIVENESS TO PIK3/mTOR INHIBITORS
EP2691539B1 (en) 2011-03-31 2018-04-25 The Procter and Gamble Company Methods for identifying and evaluating skin-active agents effective for treating dandruff
US9677138B2 (en) 2012-05-20 2017-06-13 Trustees Of Boston University Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
WO2013190092A1 (en) 2012-06-21 2013-12-27 Philip Morris Products S.A. Gene signatures for copd diagnosis
US20140255413A1 (en) 2013-03-07 2014-09-11 Boehringer Ingelheim International Gmbh Combination therapy for neoplasia treatment
EP3626308A1 (en) 2013-03-14 2020-03-25 Veracyte, Inc. Methods for evaluating copd status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP3169814B1 (en) 2014-07-14 2022-05-04 Veracyte, Inc. Methods for evaluating lung cancer status
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3215170A4 (en) 2014-11-05 2018-04-25 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
EP4180531A3 (en) 2016-05-12 2023-08-23 Trustees of Boston University Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640268A (en) * 1965-10-23 1972-02-08 Hugh J Davis Method and device for biopsy specimen collecting and handling
US4641662A (en) * 1984-09-28 1987-02-10 Jaicks John R Endocervical curette system
US4800896A (en) * 1985-11-08 1989-01-31 Jalowayski Alfredo A Cell sample collector probe
US5726060A (en) 1991-09-17 1998-03-10 Bridges; Michael Anthony Method for culturing mammalian respiratory epithelial cells
US5422273A (en) * 1993-03-23 1995-06-06 Baal Medical Products, Inc. Cell collection apparatus
US5876978A (en) 1993-04-06 1999-03-02 Medical College Of Ohio Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
US5477863A (en) * 1993-04-14 1995-12-26 Grant; Michael A. Collection kit with a sample collector
US5440942A (en) * 1994-02-02 1995-08-15 Hubbard; Stephen H. Biological sample collecting and holding device
US5795782A (en) 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US6085907A (en) * 1998-05-08 2000-07-11 Institute Of Legal Medicine, University Of Bern Foldable cardboard box for contact-free drying and long-term storage of biological evidence recovered on cotton swabs and forensic evidence collection kit including same
WO1999060160A1 (en) 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer
US6204375B1 (en) 1998-07-31 2001-03-20 Ambion, Inc. Methods and reagents for preserving RNA in cell and tissue samples
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US6746846B1 (en) * 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
CA2386987A1 (en) 1999-10-18 2001-04-26 Dennis Marshall-Fraser Sample taking device
US6383804B1 (en) 2000-07-13 2002-05-07 International Bioproducts, Inc. Sampling device with snap-off head and method of use
AU2001281136A1 (en) 2000-08-04 2002-02-18 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
US20020160388A1 (en) 2000-11-20 2002-10-31 Roberto Macina Compositions and methods relating to lung specific genes and proteins
AU2002236507A1 (en) 2000-11-29 2002-06-11 Cangen International Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
US6972181B2 (en) 2001-01-12 2005-12-06 Mount Sinai School Of Medicine Of New York University Differential diagnosis of cancer and other conditions based on expression of p63
WO2003040325A2 (en) 2001-02-01 2003-05-15 Curagen Corporation Novel proteins and nucleic acids encoding same
NZ528205A (en) * 2001-03-12 2006-09-29 Monogen Inc Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
AU2002250285A1 (en) * 2001-03-14 2002-09-24 Medical College Of Ohio Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma
CA2444691A1 (en) 2001-04-18 2002-10-31 Protein Design Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
JP2005503145A (ja) 2001-08-16 2005-02-03 ザ ユナイテッド ステイツ オブ アメリカ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 非小細胞肺癌の分子特性
US20040009489A1 (en) * 2001-09-28 2004-01-15 Golub Todd R. Classification of lung carcinomas using gene expression analysis
US20040005294A1 (en) * 2002-02-25 2004-01-08 Ho-Young Lee IGFBP-3 in the diagnosis and treatment of cancer
CA2480045C (en) * 2002-03-28 2013-09-24 Medical College Of Ohio Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
DE10219117C1 (de) 2002-04-29 2003-10-30 Adnagen Ag Verfahren zur Stabilisierung von RNS und Verwendungen von Stabilisierungspuffern
US20040063120A1 (en) * 2002-07-10 2004-04-01 The Regents Of The University Of Michigan Expression profile of lung cancer
UA82205C2 (en) * 2002-09-30 2008-03-25 Байер Фармасьютикалз Корпорейшн Fused azole-pyrimidine derivatives
WO2004070062A2 (en) * 2003-02-04 2004-08-19 Wyeth Compositions and methods for diagnosing and treating cancers
US20040241725A1 (en) * 2003-03-25 2004-12-02 Wenming Xiao Lung cancer detection
WO2004091511A2 (en) 2003-04-10 2004-10-28 Genzyme Corporation Compositions and methods to diagnose and treat lung cancer
EP3305919A1 (en) 2003-06-10 2018-04-11 The Trustees of Boston University Detection methods for disorders of the lung
WO2004111197A2 (en) 2003-06-10 2004-12-23 Trustees Of Boston University Gene expression signatures, methods and compositions for diagnosing disorders of the lung
CA2552686A1 (en) 2003-11-12 2005-05-26 Trustees Of Boston University Isolation of nucleic acid from mouth epithelial cells
WO2005086679A2 (en) * 2004-03-05 2005-09-22 Medical College Of Ohio Methods and compositions for assessing nucleic acids and alleles
WO2006056080A1 (en) 2004-11-29 2006-06-01 Diagnocure Inc. Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
EP2283831A3 (en) * 2004-12-03 2013-10-23 Merck Sharp & Dohme Corp. Biomakers for pre-selection of patients for anti-IGF1R therapy
US7862995B2 (en) * 2004-12-10 2011-01-04 Targeted Molecular Diagnostics Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
EP1851332A4 (en) * 2005-01-21 2010-05-26 Gene Express Inc METHOD AND COMPOSITIONS FOR THE EVALUATION OF NUCLEIC ACIDS
US20100035244A1 (en) 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
JP2009507229A (ja) * 2005-09-02 2009-02-19 ザ・ユニバーシティ・オブ・トレド 生物学的状態の診断及び／又は治療に有用なバイオマーカーを同定するための方法及び組成物
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
US7832459B2 (en) 2007-08-30 2010-11-16 Phillips Plastics Corporation Methods, tools, and products for molded ordered porous structures
JP2010538680A (ja) 2007-09-19 2010-12-16 ザ トラスティーズ オブ ボストン ユニバーシティー 肺疾患に対する薬剤開発のための新規経路の同定
US20090246779A1 (en) 2008-02-15 2009-10-01 University Of Washington Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-cgh
US20100055689A1 (en) * 2008-03-28 2010-03-04 Avrum Spira Multifactorial methods for detecting lung disorders
WO2010054233A1 (en) 2008-11-08 2010-05-14 The Wistar Institute Of Anatomy And Biology Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers
EP2470897A4 (en) 2009-08-28 2013-05-29 Asuragen Inc MICRO-RNA BIOMARKERS OF PULMONARY DISEASE
WO2012094744A1 (en) 2011-01-11 2012-07-19 University Health Network Prognostic signature for oral squamous cell carcinoma
US20120288860A1 (en) 2011-05-12 2012-11-15 George Mason University Differential gene expression for detecting and/or differentiating lung disease
EP2751292A4 (en) 2011-09-01 2015-05-20 Allegro Diagnostics Corp METHOD AND COMPOSITIONS FOR DETECTING CANCER BASED ON MIRNA EXPRESSION PROFILES
WO2013049152A2 (en) 2011-09-26 2013-04-04 Allegro Diagnostics Corp. Methods for evaluating lung cancer status
EP2823306A4 (en) 2012-03-09 2015-11-11 Caris Life Sciences Switzerland Holdings Gmbh BIOMARKER COMPOSITIONS AND METHODS
WO2013163568A2 (en) 2012-04-26 2013-10-31 Allegro Diagnostics Corp. Methods for evaluating lung cancer status
US9677138B2 (en) 2012-05-20 2017-06-13 Trustees Of Boston University Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease
EP3626308A1 (en) 2013-03-14 2020-03-25 Veracyte, Inc. Methods for evaluating copd status
CN109504768A (zh) 2013-03-15 2019-03-22 威拉赛特公司 用于诊断肺病的生物标记物及其使用方法
EP3169814B1 (en) 2014-07-14 2022-05-04 Veracyte, Inc. Methods for evaluating lung cancer status
EP4180531A3 (en) 2016-05-12 2023-08-23 Trustees of Boston University Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
US10927417B2 (en) 2016-07-08 2021-02-23 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
CN109689892A (zh) 2016-09-07 2019-04-26 威拉赛特公司 用于检测寻常型间质性肺炎的方法和系统

Similar Documents

Publication Publication Date Title
JP2010538680A5 (https=)
Hachiya et al. Genome-wide identification of inter-individually variable DNA methylation sites improves the efficacy of epigenetic association studies
ES2384107T3 (es) Indicadores moleculares de pronóstico de cáncer de mama y predicción de la respuesta al tratamiento
Chung et al. How variability in clinical phenotypes should guide research into disease mechanisms in asthma
Bakulski et al. DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood
US10570454B2 (en) Methods of identifying individuals at increased risk of lung cancer
Peretz et al. Diesel exhaust inhalation and assessment of peripheral blood mononuclear cell gene transcription effects: an exploratory study of healthy human volunteers
Hansen et al. A decade with whole exome sequencing in haematology
Langie et al. Whole-genome saliva and blood DNA methylation profiling in individuals with a respiratory allergy
JP2012531195A5 (https=)
Martin et al. Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2. 2
Hong et al. Epigenetics and development of food allergy (FA) in early childhood
JP2014012007A5 (https=)
Qin et al. Dysregulation of sputum columnar epithelial cells and products in distinct asthma phenotypes
Voskamp et al. Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge
De Boever et al. Characterization of the peripheral blood transcriptome in a repeated measures design using a panel of healthy individuals
JP2019512212A (ja) 活動性結核を検出するための方法
US12084719B2 (en) RNA editing as biomarkers for mood disorders test
Górska et al. DNA methylation profile in patients with indolent systemic mastocytosis
Vyhlidal et al. Detecting gene expression in buccal mucosa in subjects with asthma versus subjects without asthma
JP2020505928A5 (https=)
Shin et al. Asthma-predictive genetic markers in gene expression profiling of peripheral blood mononuclear cells
Orjuela et al. Prenatal PAH exposure is associated with chromosome-specific aberrations in cord blood
KR101470125B1 (ko) 알엔에이즈 2를 포함하는 아스피린에 의해 악화된 호흡기 질환 진단용 마커 조성물 및 진단용 키트
Orenga et al. Overrepresentation of TTMV9 in a Subgroup of Patients with ME/CFS